LSE - Delayed Quote GBp
Faron Pharmaceuticals Oy (FARN.L)
At close: November 7 at 6:16 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-23,806.00
-23,806.00
-22,993.00
-22,218.00
-17,479.00
Investing Cash Flow
-123.00
-123.00
-385.00
-473.00
-142.00
Financing Cash Flow
23,983.00
23,983.00
23,478.00
25,590.00
14,787.00
End Cash Position
6,876.00
6,876.00
6,990.00
6,853.00
4,108.00
Capital Expenditure
-123.00
-123.00
-385.00
-474.00
-142.00
Issuance of Capital Stock
26,031.00
26,031.00
13,445.00
25,559.00
14,103.00
Issuance of Debt
64.00
64.00
10,389.00
662.00
630.00
Repayment of Debt
-861.00
-861.00
-105.00
-122.00
-122.00
Free Cash Flow
-23,929.00
-23,929.00
-23,378.00
-22,692.00
-17,621.00
12/31/2020 - 11/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RVU.WA Ryvu Therapeutics S.A.
41.55
+4.66%
PTP.F Pentixapharm Holding AG
3.1750
0.00%
HPHA.DE Heidelberg Pharma AG
2.4000
-5.51%
GENO.ST Genovis AB (publ.)
20.00
-0.25%
ALTME.PA TME Pharma N.V.
0.1432
+3.02%
ULTI.OL Ultimovacs ASA
1.8500
0.00%
SIGHT.PA GenSight Biologics S.A.
0.3150
+0.80%
NYKD.OL Nykode Therapeutics AS
4.2920
+0.42%
MDG1.DE Medigene AG
1.5420
-5.63%
RCE.AX Recce Pharmaceuticals Ltd
0.4700
0.00%